Qube Research & Technologies Ltd
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1729829
LONDON, X0
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$38,270,738
-$691,601 QoQ
Shares Held
668,835
-3.0% QoQ
Ownership
0.346%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#50
of 564 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Derivatives in BMRN
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$1,056,814
PutShares
12,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. BMRN ranks #19 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in BMRN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,270,738 | 668,835 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $38,962,339 | 689,721 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $85,379,455 | 1,436,639 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,094,002 | 260,229 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,202,403 | 640,393 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $432,240 | 6,576 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $1,152 | 14 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,296,911 | 14,849 | Shares | Sole | 2024-05-14 | |
| 2024-03-31 | $1,056,814 | 12,100 | Put | Sole | 2024-05-14 | |
| 2023-12-31 | $1,015,302 | 10,530 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,226,604 | 81,675 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $42,404,289 | 489,205 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $46,359,267 | 476,751 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $27,452,792 | 265,270 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,081,717 | 95,337 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $20,722,938 | 268,780 | Shares | Sole | 2022-05-09 | |
| 2021-09-30 | $1,870,804 | 24,205 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,164,238 | 13,953 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $812,185 | 10,756 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $3,965,137 | 52,118 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $766,188 | 6,212 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||